IL7R and Hepatic fibrosis: Among HCV-infected patients, IL7RA polymorphisms have been associated with the response to peg-interferon (IFN)-α/ribavirin therapy against HCV and severe liver fibrosis in HIV/HCV-coinfected patients [27,28].